Cargando…
The utility of biomarkers in traumatic brain injury clinical management
Autores principales: | Rodríguez-Rodríguez, Ana, Egea-Guerrero, Juan José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114747/ https://www.ncbi.nlm.nih.gov/pubmed/27855696 http://dx.doi.org/10.1186/s13054-016-1545-5 |
Ejemplares similares
-
Acute coagulopathy in trauma: with or without shock? That is the question
por: Egea-Guerrero, Juan José, et al.
Publicado: (2014) -
H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury
por: Lagerstedt, Linnéa, et al.
Publicado: (2017) -
Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury
por: Lagerstedt, Linnéa, et al.
Publicado: (2018) -
Inflammatory Biomarkers of Traumatic Brain Injury
por: Johnson, Nathan H., et al.
Publicado: (2022) -
Neuroinflammatory responses to traumatic brain injury
por: Paiva, Wellingson Silva, et al.
Publicado: (2015)